Compare PayPal Holdings, Inc. (PYPL) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

PayPal (PYPL) trades at $53.18, down 3.24% on the day, with a bearish technical outlook but strong fundamentals including a P/E of 10.05 and net income margin of 14.36%. Recent earnings beat expectations in Q1 and Q2 2026, while the company pursues a $1.5B cost-saving initiative and expands beyond branded checkout. Analyst consensus is a $59.61 price target with a mixed rating distribution.

The stock presents a value opportunity given low valuation multiples and solid profitability, but faces headwinds from competitive pressures and recent takeover speculation collapse. Upside depends on successful execution of restructuring and new growth initiatives, while downside risks include market sentiment shifts and execution missteps.

XRAY trades at $10.99, down 3.43% on the day, reflecting ongoing challenges amid a bearish technical signal. The company reported a Q2 2026 earnings beat but faces declining revenue and negative profitability, with a net income margin of -14.99%. Cash flow trends show volatility, and the debt-to-asset ratio has worsened to 42.88% in 2025. Recent news highlights margin pressure and a class-action lawsuit inquiry, clouding the near-term outlook despite some institutional buying interest.

The investment outlook is cautious. While the stock trades below the consensus price target of $12.50, persistent net losses, high debt, and competitive pressures pose significant risks. Analyst sentiment is mixed with a 'Hold' consensus, suggesting limited upside until the company demonstrates sustained operational improvement and revenue stabilization.